Arylsulfatase B deficiency in maroteaux-lamy syndrome: Cellular studies and carrier identification

Nicholas G. Beratis, Bryan M. Turner, Roberta Weiss, Kurt Hirschhorn

Research output: Contribution to journalArticlepeer-review

47 Scopus citations

Abstract

Arylsulfatase B activity was studied in peripheral leukocytes obtained from 11 normal subjects, 2 obligate heterozygotes for Maroteaux-Lamy syndrome (MLS), and 1 homozygote for MLS. The activity (mean ± SD) \yas 113.7 ± 36.2 (range 57.4 181.8), 31.0 (25.7-34.5), and 5.0 nmol 4-nitrocatechol/mg protein/hr, respectively. Although overlap occurred on two occasions between adjacent groups on single enzyme determinations, no overlap was observed between normal subjects, heterozygotes, and the homozygote when the mean activities of replicate assays performed were considered. In two normal siblings of the patient, sibling 1 and sibling 2, the activity was 50.1 and 106.3, respectively. Arylsulfatase B activity in cultured skin fibroblasts derived from 14 normal subjects, the 2 obligate heterozygotes for MLS, and the patient was 145.2 ± 4.6 (82.7-178.7), 58.5 (49.3-67.6), and 7.0, respectively. Occasional overlap between normal subjects and heterozygotes again occurred with single enzyme determinations, but there was no overlap between the mean values of replicate assays performed on each case. Sibling I and sibling 2 showed activity of 51.0 and 96.0, respectively, confirming the leukocytes. Arylsulfatase B activity in cultured skin fibroblasts of 11 patients with 7 other inborn errors ol metabolism, including patients with Hurler’s syndrome, Hunter’s syndrome, and metachromatic leukodystrophy was within normal range. The lysosomal enzymes arylsulfatase A (EC. 3.1.6.1), a-D-galatosidase (EC. 3.2.1.22), a-glucosidase (EC. 3.2.1.20), a- L-iduronidase (EC. 3.2.1.76), a-D-mannosidase (EC. 3.2.1.24), a-L-fucosidase (EC. 3.2.1.51), /?-D-galactosidase (EC. 3.2.1.23), /3-D-glucosidase (EC. 3.2.1.21), and /3-D-glucuronidase (EC. 3.2.1.31) were normal in cultured skin fibroblasts of the patient with MLS. No arylsulfatase B activity was detected in a long term lymphoid cell line established from the patient with MLS. The arylsulfatase B activity in 10 normal lymphoid cell lines was 25.2 ± 5.6 with a range of 15.8-31.8. In cultured amniotic fluid cells from 10 normal pregnancies the arylsulfatase B activity was 203.2 ± 49.9, with a range of 136.3-302.7. The findings indicate that peripheral leukocytes, cultured skin fibroblasts, and long term lymphoid cell lines can be used for the diagnosis of MLS, and that carrier detection is possible. Also the finding of arylsulfatase B activity in cultured amniotic fluid cells suggests that prenatal diagnosis of MLS is feasible.

Original languageEnglish
Pages (from-to)475-480
Number of pages6
JournalPediatric Research
Volume9
Issue number5
DOIs
StatePublished - May 1975

Fingerprint

Dive into the research topics of 'Arylsulfatase B deficiency in maroteaux-lamy syndrome: Cellular studies and carrier identification'. Together they form a unique fingerprint.

Cite this